Legal and Regulatory Issues in Self-Care Pharmacy Practice

Frier Levitt Clinician-Attorney and Senior Counsel authored Chapter 4 of Handbook of Nonprescription Drugs titled “Legal and Regulatory Issues in Self-Care Pharmacy Practice” , 20th ed. This is an authoritative resource for pharmacists and pharmacy students.

Published: December 2020
ISBN: 1-58212-317-9
https://doi.org/10.21019/9781582123172
Daniel L. Krinsky

Legal and Regulatory Issues in Self-Care Pharmacy Practice

Illinois PBM Reforms: Audit Rights, Spread Pricing Prohibition, Rebate Pass-Through Mandate, and Enforcement Tools for Covered Entities and Plan Sponsors

Jesse Dresser and Edgar Asebey Featured in CNN Health: “The future of peptides in the US is about to become clearer. Here’s what you should know”

Jesse Dresser Featured in Forbes: “Peptides May Soon Be Legal. These Companies Are Ready To Cash In”

Edgar J. Asebey Featured in Law360: “What To Know: FDA Compounding Panel Weighs Peptides”

Jesse Dresser Featured in CNN Business: “The world is desperate for weight-loss drugs. But Big Pharma can’t advertise them globally”

Direct-to-Employer Conference Insights – Direct to Employer Models and Specialty Care

A.J. Barbarito Presents at Pennsylvania Pharmacists Association Independent Owners Forum

Can a PBM Terminate Your Pharmacy Over a Small Audit Discrepancy? FAQs About PBM Audits, Network Terminations, and Appeal Rights

Legal and Regulatory Issues in Self-Care Pharmacy Practice

Related Insights

Illinois PBM Reforms: Audit Rights, Spread Pricing Prohibition, Rebate Pass-Through Mandate, and Enforcement Tools for Covered Entities and Plan Sponsors

Jesse Dresser and Edgar Asebey Featured in CNN Health: “The future of peptides in the US is about to become clearer. Here’s what you should know”

Jesse Dresser Featured in Forbes: “Peptides May Soon Be Legal. These Companies Are Ready To Cash In”

Edgar J. Asebey Featured in Law360: “What To Know: FDA Compounding Panel Weighs Peptides”

Jesse Dresser Featured in CNN Business: “The world is desperate for weight-loss drugs. But Big Pharma can’t advertise them globally”

Direct-to-Employer Conference Insights – Direct to Employer Models and Specialty Care

A.J. Barbarito Presents at Pennsylvania Pharmacists Association Independent Owners Forum

Can a PBM Terminate Your Pharmacy Over a Small Audit Discrepancy? FAQs About PBM Audits, Network Terminations, and Appeal Rights